Neil Parry

Neil Parry has led the Biotechnology science area at Unilever since 2005, to focus on business with the view to develop the interaction with innovative partners and support advancing new technologies. Neil's current teams comprise of both scientists located internally and externally with collaborators and he is constantly on the lookout for new biotechnologies and their potential. At Unilever Neil has worked on enzymes and protein technology for chemical businesses and the antibody company Unipath. 

Previously he has held project leader posts in Biorecognition and Life Sciences and teams making key inventions in exploitation of protein domains in industrial applications. Following the sale of Unipath, Neil continued in Life Sciences as the Science Leader within the biotechnology department with a focus on intervention technologies for a range of HPC categories and a wider range of bio based materials. During this time he jointly established a spin out company with Unilever Ventures for applications of biomolecules in the pharma and agrochemical industry.

He obtained his first degree in Biology at Portsmouth University in 1993, focusing his final year in enzymology which later became the focus for his career.  And completed a PhD in Enzyme Biotechnology in 1996 which enabled him to work in a number of EU labs and industry groups as part of the consortium (including molecular biology in Seville University; expression and downstream processing at the University of Athens; enzyme biochemistry in the University of Gent).